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Abstract  
 
The European Union (EU) initiative on the Digital Transformation of Health and Care (Digicare) 
aims at providing conditions for building a secure, flexible and decentralised digital health 
infrastructure. Creating a European Health Research and Innovation Cloud (HRIC) within this 
environment should enable data sharing and analysis for health research across the EU in 
compliance with data protection legislation while preserving the full trust of the participants. 
Such a HRIC should learn from and build on existing data infrastructures, integrate best 
practices, and focus on the concrete needs of the community in terms of technologies, 
governance, management, regulation and ethics requirements. Here we describe the vision 
and expected benefits of digital data sharing in health research activities and a roadmap 
fostering the opportunities while answering the challenges of implementing a HRIC. For this, 
we put forward five specific recommendations and action points to ensure that a European 
HRIC: 1) is built on established standards and guidelines, providing cloud technologies through 
an open and decentralised infrastructure; 2) is developed and certified to the highest 
standards of interoperability and data security that can be trusted by all stakeholders; 3) is 
supported by a robust ethical and legal framework compliant with the EU General Data 
Protection Regulation (GDPR); 4) establishes a proper environment for the training of new 
generations of data and medical scientists; 5) stimulates research and innovation in 
transnational collaborations through public and private initiatives and partnerships funded by 
the EU through Horizon 2020 and Horizon Europe. 
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 3 
 
Background 
 
Genomics has brought life sciences into the realm of data sciences - large scale DNA and RNA 
sequencing is now routine in life-science and biomedical research with an estimate of up to 
60 million human genomes being available in the coming years [1, 2]. Recent innovations in 
medical research and healthcare, such as high-throughput genome sequencing, 
transcriptomics, proteomics, metabolomics, single-cell omics techniques, high-resolution 
imaging, electronic medical records (EMRs), big-data analytics and a plethora of internet-
connected health devices fundamentally change the infrastructure requirements for health 
research. 
Translating these new data together with clinical information into scientific insights and 
actionable outcomes for improving clinical care is a major challenge. As life-science and health 
research datasets rapidly grow larger, with an ever-increasing number of study participants 
required to detect meaningful but weak signals that may be blurred by a myriad of 
confounding biological, experimental or environmental factors, the computational resources 
required to process and analyse this big data increasingly outgrows the capabilities of even 
large research institutes. The various cloud technologies and services listed in Table 1 are 
based on shared commercial and private computer and storage resources that can be 
provided on demand to users from a large number of different institutions conducting or 
participating in joint projects. They have emerged as powerful solutions to the challenges of 
collaborating in research on genomic, biomedical and health data. Biomedical and health 
research has yet to fully enter the big data and cloud computing era. The HRIC, as described 
in this manuscript, would help facilitate this transition, providing access to larger datasets, 
cutting-edge tools and knowledge, as envisioned in [3]. For example, the HRIC should ease the 
incorporation of domain expert knowledge into systems disease maps in a format that can be 
both understood by all stakeholders (patients and clinicians, scientists and drug developers), 
and processed by a high-performance computers, thus supporting the development of 
innovative medicines and diagnostics [4, 5]. Cloud technologies (through e.g. Hadoop 
applications) makes it possible to collaborate, access and reuse data also in situations when 
privacy concerns or regulation prohibits remote users from downloading data – an important 
benefit in Europe where national regulations can differ significantly. Clouds allow bringing 
algorithms to the data and as such can enable data sharing and joint processing without 
generating unnecessary copies of the data, which comes with potential benefits for data 
protection [6, 7]. Clouds, additionally, enable performing computational analyses at a scale 
that individual institutions would struggle to manage [7]. Consequently, in the last few years 
the large international cancer and other genomics consortia have created specialized 
genomics and biomedical cloud environments, each supporting individual projects [2]. These 
projects have made important advances in connecting health research data across disciplines, 
organisations and national boundaries. For instance, in research on rare diseases, 
international collaborations that integrate genomic, phenotypic, and clinical data have 
introduced new paradigms in diagnosis and care [8]. However, a project-based, fragmented 
landscape will not enable access and construction of large data cohorts that are required to 
address novel or broader biomedical questions that were not anticipated in individual projects 
when collecting inform consent from the participants, nor will it provide adequate data 
governance and containable cost models.  
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 4 
Scaling and sustainably managing such solutions to support all European life scientists thus 
requires a coordinated action from science policy makers, funders and other actors in this 
complex ecosystem. Connecting Europe’s health data to advance the understanding of life and 
disease requires that research data and analysis tools, standards and computational services 
are made FAIR – i.e. findable, accessible, interoperable, and reusable for researchers across 
scientific disciplines and national boundaries [9]. Truly enabling personalised and digital 
medicine across Europe and beyond will require a connected digital infrastructure for 
Europe’s health data that supports systematic openness and integration of research data with 
real-world datasets (e.g. environmental monitoring data) generated inside all healthcare 
systems, government agencies, foundations and private organisations that will adopt it. 
On the 13th of March 2018, the Health directorate of the Directorate-General for Research and 
Innovation of the European Commission of the EU organised a workshop to explore the 
possibility and challenges involved in establishing a cloud for health research and innovation, 
accessible by researchers and health professionals throughout Europe, in line with 
recommendations for a European Innovation Council and the Horizon Europe 2021-2027 
framework programme [10, 11]. The cloud computing environment proposed in this 
manuscript builds upon the European Open Science Cloud (EOSC) initiative developed in the 
last few years by the European Commission [12], with a focus in the life science and medicine 
field. The EOSC aims at developing a trusted, open environment for the scientific community 
for storing, sharing and re-using scientific data and results. Overall, the authors feel that the 
cloud described in this manuscript, providing the biomedical and health research community 
with the technical infrastructure and services listed in Table 1 to support the development of 
innovative diagnostics methods and medical treatments, should become an integral part of 
the EOSC. The workshop gathered a broad range of experts from multiple biomedical research 
disciplines, health care, informatics, ethics and legislation, including representatives of more 
than 45 FP7 and Horizon 2020 (H2020) EU-funded collaborative projects. The participants 
explored requirements and developed a set of recommendations for a European “Health 
Research and Innovation Cloud” (HRIC) to connect researchers and health data sources in 
Europe [13] such that clinical data, software, computational resources, methods, clinical 
protocols, and publications, can be more widely and securely accessed and reused following 
the FAIR principles [9] than is currently possible with existing European research infrastrucures 
such as ELIXIR that form a network of heterogenous national nodes. For example, the HRIC 
infrastructure would benefit from the aforementioned advantages of cloud computing for the 
archiving and dissemination of health data.  This paper summarises the main conclusions from 
the workshop and highlights five recommendations and action points to the EU and national 
stakeholders (Table 2). The recommendations are key issues that need to be addressed in 
order to link biological, clinical, environmental and lifestyle information (from single 
individuals to large cohorts) to the health and wellbeing status of patients and citizens over 
time, while making this wealth of data and information available for European health research 
and innovation in clinical care. 
  
The HRIC should be built on established standards and guidelines, to foster European-wide 
medical research 
 
Rationale 
Sharing of data, information and knowledge represents the most important functionality in 
the context of a HRIC. High-level standardisation, common exchange mechanisms, interfaces 
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 5 
and protocols, and semantic interoperability form the foundation for widespread adoption of 
the  FAIR principles [9] in health research.  Data shared collaboratively in such health-related 
cloud projects are now largely standardised for the processing of genomic DNA read and 
genomic variant calling files. By comparison, the sharing of highly sensitive clinical and health 
data has thus far been much less developed hence representing a key future focus area, and 
numerous challenges remain with regard to sharing these data in a meaningful way. 
 
Existing standards and guidelines 
Many individual projects, in Europe and globally, have demonstrated the opportunities and 
the added value presented by connecting and exchanging data across countries via 
standardised protocols. Table 3 lists recent European projects that have developed towards 
clinical and health data exchange via cloud-based solutions. All those projects have developed 
and implemented worthy ideas that should be included in the HRIC. However, we envision the 
HRIC as a disease-agnostic environment, and on a larger scale than the platforms mentioned 
in Table 3. Moreover, the HRIC should not be tied to a single project or consortium, but should 
rather be under the governance of an independent body. International exchange of health 
research data holds tremendous potential in disease research by facilitating better 
investigation of disease causality and linking of genotypes and phenotypes, such as 
demonstrated in the Pan-Cancer Analysis of Whole Genomes (PCAWG) project, for example. 
An important aspect of the cloud-based data governance is that it allows sharing of data 
outside a consortium through a data request mechanism and a governance infrastructure that 
track participant consent, and data access. The cloud-based audit trail capabilities of the 
cloud-based research analyses that can be implemented at both data and infrastructure levels 
is a direct benefit to the data controllers. A standardised data model (or data access model) 
and/or standardised metadata models facilitate consolidation of different data sets and 
significantly increase the findability, the semantic interoperability and, by consequence, the 
reusability of data, and thus its ‘FAIRness’ [9, 14]. 
Workshop participants agreed that a first minimalistic and yet effective approach to data 
exchange should consist of a small number of initial online repositories containing references 
(e.g. links to render data sets findable) along with metadata (e.g. type and scale of content, 
specifications describing in what systems the data set may be stored and processed), and 
indications on how to gain access (e.g. requirements and point of contact). This could be 
designed as a metadata repository containing the metadata of data objects and information 
on how to gain access to them. The data objects as such may, or indeed should, be stored 
elsewhere.  
Beyond their metadata, however, data sets are bound to greatly differ, as research projects 
vary largely in scope. Not only would it be cumbersome to record a large number of 
parameters irrelevant to the specific question addressed, but it would also be problematic 
from an ethical viewpoint, considering patient personal data protection aspects [15]. It 
therefore seems more promising to drive standardisation within research communities while 
looking out for opportunities for overall standardisation. 
Thus, the workshop envisioned the HRIC as a distributed collection of data repositories, people 
and services, which together make up a framework to share and operate as a federated data 
commons with reproducible software, standards and expertise based on joint policies and 
guidelines to conduct health research as performed successfully in previous initiatives [2, 16-
19]. The need for federation is also highlighted in the proposed EU action plan for ‘Making 
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sense of big data in health research’ [3]. Creating such a HRIC opens new frontiers for research 
and healthcare via the opportunities for strong international collaborations. 
Beyond Europe the HRIC should collaborate internationally to drive the development and 
widespread adoption of global standards and connectivity. Ongoing initiatives exist outside 
Europe that are aiming at developing global standards for the secure exchange of e.g. health 
and medical records within health information federations while tracking completeness of the 
supporting data [20, 21], as well as developing guidelines for data analytics and standardised 
workflows. They should be considered for the basis of the HRIC as this will provide the 
scientific community with means of reproducibility, version control and documentation, which 
will be an important vehicle to drive increased standardisation and connectivity. 
 
 
A European HRIC should be developed and certified to the highest standards of 
interoperability and data security 
 
Rationale 
The workshop participants enthusiastically endorsed the vision of the HRIC as a federated 
environment. Through work on the standardisation, harmonisation and integration of 
genomic data with other health-relevant information to optimise hypothesis-driven analyses, 
the major blockers for cross-border collaborations in translational research on disease 
prevention, treatment and management will be addressed through a federated HRIC 
infrastructure in which data sources remain at their location of origin and are made accessible 
to users through a metadata repository. Moreover, data security has to be integral to the 
development of the HRIC, using modern cryptology and access control techniques to ensure 
the protection of the patients’ data contained therein. 
 
Standards in interoperability and data security 
European health systems have different ways of managing and storing health data, making 
the exchange of clinical data between the EU member states complex. The challenges are well 
illustrated by the use of eHealth records and their use as secondary research material. In a 
recent OECD report [22] ten countries reported comprehensive record sharing within one 
country-wide system designed to support each patient having only one EHR (Supplementary 
Table.). These countries are Estonia, Finland, France, Greece, Ireland, Latvia, Luxembourg, 
Poland, Slovakia and the United Kingdom (England, Northern Ireland, Scotland and Wales). In 
these countries, plans call for patient records to be shared among physician offices and 
between physicians and hospitals regarding patient treatment, current medications, and 
laboratory tests and medical images. Some have already implemented part or all these 
functionalities, while others are progressing toward it. In other countries key aspects of record 
sharing are managed at sub-national level only, such as within provinces, states, regions or 
networks of health care organisations (for example, Austria, Germany, Italy, Netherlands, 
Sweden, and Spain; Supplementary Table). Among them, all have implemented or are 
planning the implementation of a national information exchange that enables key elements 
to be shared country-wide. Based on the recent reports of the European Commission [23], 
Belgium, Malta, Portugal, Romania and Slovenia are now developing national EHR systems, 
leading to a total of 16 EU member states providing such services. 
Within the framework of the Joint Action on Rare Cancers, an EU initiative that brings together 
European research centres, policy makers and other stakeholders with the aim to set the 
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 7 
agenda at national level, an analysis was made on the status of eHealth medical records in the 
EU member states. This work builds on the OECD study and complements this with 
information provided by the European Commission on the national laws on EHRs in the EU 
member states [24]. Thus all EU countries are investing in the development of clinical EHRs, 
but only some countries are moving forward the possibility of data extraction for research, 
the provision of statistics and the enablement of other uses that serve the public interest (P. 
Bogaert, personal communication). Countries that develop EHR systems that combine or 
virtually link data together to capture patient health care histories have the potential to be 
used also for long-term follow-up of cancer patients. Figure 1 shows how data from various 
sources can be integrated to provide a full picture of patients’ health status over time and 
carry out research for patterns and anomalies in large populations using the specific 
combinations of data and analysis resources relevant for each research project, while ensuring 
compliance with security and data protection regulations. 
The H2020-funded project European Open Science Cloud (EOSC)-Life [25] is developing 
policies, specifications and tools for the management of data for biological and medical 
research including  aspects of eHealth data. The use of common metadata standards, 
developed in EOSC-Life, as a foundation for remote data discovery and access was emphasised 
by the workshop participants as a key enabler for the HRIC. For instance, practical and legal 
considerations for cloud computing of patient data, which include the responsible use of 
federated and hybrid clouds set up between academic and industrial partners have been put 
forward by early EOSC pilot projects [26]. 
The workshop participants emphasised that sustainability aspects are critical and must be 
considered from the start. To ensure that a HRIC could respond properly to emerging needs, 
innovation and technology changes, a distributed federated storage solution offering access 
to FAIR data and services should be built according to modularity principles. In particular, due 
to the long-term nature of a HRIC, due consideration should be given to deploying generic and 
modular computational methods and/or data storage management systems, while the 
information and communications technology (ICT) infrastructure should be flexible, portable 
and expandable.  
The million European genomes initiative [27] is a case in point: eighteen member states have 
already signed the Genomics Declaration of Cooperation [28] to enable cross-border access 
to genomic databases and other health information. This federation of national initiatives [28] 
will provide secure access to such data resources in the member states to enable the discovery 
of personalised therapies and diagnostics for the benefit of patients. The initiative involves 
aligning strategies of ongoing national genomic sequencing campaigns with complementary 
de novo genome sequencing to obtain a total cohort of 1 million Europeans, accessible in a 
transnational framework, by 2022 [29]. The HRIC would form a basis for such large-scale, 
permanent collaborations. 
The workshop participants recognise that ensuring a maximal data security is paramount to 
build and maintain trust with the European citizens. To address this issue, we suggest using 
modern cryptology such as blockchain to ensure data security by design, and holding regular 
data security assessment (e.g. through hackathons and/or commercial security audits). As 
shown in recent literature, the use of blockchain in biomedical research is still in its infancy 
[30]. However, blockchain or other advanced cryptology tools that can be used to protect data 
in a cloud environment could prove useful for the secure and trustworthy implementation of 
the HRIC [31]. 
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 8 
The HRIC must be supported by a robust ethics and legal framework compliant with the 
GDPR 
 
Rationale 
Compliance with GDPR and other data protection laws, as well as enforcing an ethical usage 
of data is paramount to gain the general public’s support and trust in the HRIC.  
 
Existing ethics and legal framework 
Unblocking the legal and administrative barriers for sharing human research data across 
geographical and organisational boundaries will, if the trust of research participants is 
preserved, pave the way for continent-scale cohorts in life science research. This will represent 
a significant innovation as sharing and joint analysis of sensitive data has until now been 
severely limited because of the different restrictions inherent to the different classes of 
sensitive data. By using a federated database model, with a metadata repository within the 
HRIC cloud encrypted environment, data security is maintained while innovative data analyses 
can be performed by bringing the algorithms to the data rather than centralizing the data [32]. 
Federation, rather than full integration of all available resources, poses an important challenge 
for implementation and deployment of an effective HRIC. The set-up and functioning of a HRIC 
requires a robust foundation of legal agreements and ethics rules and procedures, as well as 
security and data protection compliance protocols. Importantly these elements must be 
introduced during the conception and design phase as part of its governance. This is essential 
in order to allow the different HRIC actors providing access to their data sources, managing 
them within the cloud, and accessing these resources to incorporate policy requirements into 
the design and manage the complexity involved in implementing simple and intuitive user 
interfaces and project portals. This may be challenging considering the heterogeneity of health 
systems and health market accesses across Europe and will need the sharing of a common 
agreed vision across EU member states.  
Ethical, societal and privacy considerations for (re)using health related data have been 
outlined in the Code of Practice on Secondary Use of Medical Research Data developed in the 
European Translational Information and Knowledge Management Services (eTRIKS) project 
funded by the Innovative Medicines Initiative (IMI) [33]. In addition to clear and explicit 
consent, explicit dissent may need to be considered for the use/re-use of data. Ultimately, 
each citizen and patient must be able to access her/his own data and know when and where 
it has been used and for what purpose. In addition, the difficult question of the business model 
of using those data should be discussed at various levels from ethical, societal and economical 
standpoints taking into account potential future developments of products and services using 
personal medical data. Furthermore, the goal of providing the citizens with personalised 
services requires technical advancements in the collection and analysis of data (e.g. in data 
analytics and machine learning). For this type of usage, simple consent mechanisms might not 
be sufficient. For example, how should a clear data-collection purpose statement be defined, 
if data is collected for multiple usage scenarios across a distributed/federated cloud in which 
actors from different geographical and legislative environments will need to interact and 
cooperate? Would an excessive number of consent requests minimise data provision for 
research or clinical applications? Another level of complexity is introduced by the 
heterogeneity of data protection and privacy regulations when the data originate from states 
within federated national health systems (e.g. Germany, Italy). Development of large-scale 
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 9 
European access mechanisms will require open consultation and engagement with national 
policymakers, patient organisations and the wider society to build the trust and confidence 
needed for widespread adoption and sustainable operations. 
In addition to technical, ethical and legal specifications, a global integrated governance model 
needs to be established for the HRIC in line with that of the EOSC, regulating roles and 
responsibilities of all contributing institutions and users, and procedures for authentication 
and access control to individual resources. Principles, with specific guidelines on 
implementation into a HRIC environment, will need to be developed in order to manage and 
regulate aspects such as ownership, access, transparency, sharing, integration, 
standardisation of data and metadata formats, tools and frameworks, while ensuring 
confidentiality and sustainability. All these principles need to be developed with the 
overarching objective of providing benefit to and preserving the trust of patients and the 
general public. 
Health data mostly represents sensitive data, which need to be managed to preserve the trust 
of patients, research participants and the general public, respect social norms and naturally 
comply with the rules and regulations of data protection laws, notably the EU GDPR [15]. 
Although the GDPR directly applies across the EU and its provisions prevail over national laws, 
EU member states retain the ability to introduce in their own national legislation certain 
derogations provided for by the GDPR itself. The GDPR also introduces the notions of 'Privacy 
by Design', which means that any organisation that processes personal data, must ensure that 
privacy is built into a system during the whole life cycle of the system or process; and 'Privacy 
by Default', which means that the strictest privacy settings should apply by default, without 
any manual input from the end user. In addition, any personal data provided by the user to 
enable the optimal use of a given health dataset should only be kept for the amount of time 
necessary to provide the intended product or service [15].  
Thus, successfully linking and accessing biomedical and health data across Europe will require 
many different disciplines and specialists working together with a coordination effort that 
should encompass controlled access mechanisms to ensure compliance with privacy and data 
protection regulations. Data providers need logging and monitoring functionalities to comply 
with the GDPR and to enable tracking of data and methods within the system, controlling 
instances and routines that check for the adherence of predefined standards and formats to 
guarantee data integrity. Access mechanisms need to be developed that support the 
researchers, data producers and data analysts to request permissions and fulfil reporting 
requirements for data use in national and international research projects, which represents a 
significant regulatory, political and sustainability challenge [34]. These include in particular 
considerations about the rights of patient donors and research participants, taking into 
account the data protection aspects of various legal systems and local regulations. 
Researchers have to face differences in the understanding of the right to data protection in 
those different regional or national European ecosystems. There is an urgent need for 
standardised, usable, data-protection-policy-compliant solutions for sensitive data sharing 
capable of integrating and analysing health data coming from different sources, organisations 
and potentially from different research disciplines. These aspects are subject to ongoing 
discussions and debates in the EOSC initiative [35] and for instance, progress has been made 
in the Human Brain Project through its Ethics and Society sub-project in collaboration with the 
project platforms [36, 37]. Other examples of data sharing compliant with data protection 
policies can be found in the recent literature [38-45]. Furthermore, there is the issue of 
capacity with the amount of data starting to strain the infrastructure of any individual hospital 
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or research institute. Thus, the interplay between privacy, data security and access control on 
one hand and access (including cost-recovery models) to storage, computational and analysis 
resources on the other hand will be a defining element of the policy and technology 
development of a decentralised digital health infrastructure. The evolution of a cloud model 
that could be used in European health research will also have to take into account other 
specific aspects of the GDPR [15]. For instance, the European Commission intends to facilitate 
the free flow of non-personal data in the European Digital Single Market, and for health-
related research participants it codifies the ‘right to be forgotten’. It stipulates that patient 
donors should be able to retain control over their data regardless of technological 
developments. A European HRIC could be an important enabler for researchers to comply with 
these requirements. For example, once certain conditions are met between European and 
international partners, including those pertaining to data protection and use, federated and 
hybrid clouds could facilitate the deletion of data sets once a donor exercises her/his ‘right to 
be forgotten’, which thus could minimise the necessary transfer of large raw data sets across 
borders, as the deletion can be performed in the original dataset and easily propagated to the 
relevant federated data sources. 
 
A proper training environment for HRIC developers and users should be established 
 
Rationale 
The workshop identified the lack of trained personnel, with solid skills in both medical and 
data analytical fields as one of the major bottlenecks when dealing with ‘medical big data’ [3].  
 
Need for training and ideas 
Indeed, effectively developing, operating and maintaining the HRIC will pose serious 
challenges and require the training of a new generation of data scientists able to navigate 
smoothly and efficiently between computational, security and medical disciplines. This 
includes clinical researchers, bioinformaticians, data analysts, data managers, software 
engineers, cloud engineers, other IT-specialists, ethics officers, and data protection specialists, 
which represent an essential new field of expertise. Finding professionals that cover more 
than one or two of the above-described disciplines is nearly impossible. Furthermore, 
communication between this comprehensive mix of clinical researchers, data managers and 
IT/bioinformatics specialists needs to be improved, requiring a governance structure well 
beyond that of a standard research setting. The EU should take inspiration from existing large 
and successful infrastructures that foster multidisciplinary teams, such as CERN [46, 47]. Thus, 
it is necessary to rethink the training and education of health professionals and to update 
them with the HRIC in mind, considering both international standards and practices for data 
sharing as well as national environments and regulations.  
 
Multiple funding mechanisms are required to drive the development of the HRIC and 
support its broad use in research projects 
 
Rationale 
Delivering the HRIC requires an ambitious reshaping of the European landscape for health 
data and research through appropriate funding schemes that enable transformation of 
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fragmented ICT resources and project-centric solutions for data access and governance into a 
long-term, coherent service ecosystem that can be accessed by users transnationally.  
 
Need for innovative public-private funding initiatives 
Indeed, the HRIC needs a trusted and transparent innovation approach that recognises the 
importance of a clear, long-term ambition in the programme to support the participation of 
industry and small to medium enterprises (SME) in joint projects with a broad set of societal 
actions. In particular, there is a need to support the EU ICT industrial/SME innovation 
ecosystem in order to demonstrate the benefits in advancing data sharing, integration and 
analysis across Europe, for the benefit of all citizens, thus creating a foundation for attractive 
private investments. 
For this purpose, targeted EU funding mechanisms also involving private investors need to 
support the development of HRIC-compliant services for data sharing and analysis in health-
related research projects (i.e. through reimbursement for storage and computing costs) with 
incentives to reuse and extend existing infrastructures that favour national HRIC participation 
rather than rebuilding and fragmenting solutions. Moreover, the EU ICT industrial ecosystem 
must be supported in order to alleviate the risks associated with storing and sharing data 
across cloud systems operated by non-EU companies. The EU has established a strict privacy 
and ethics policy through the implementation of the GDPR legislation, binding for all operators 
active on the EU territory [48-51].  
European funders, science policy makers and other actors need to develop mechanisms that 
bring together experience gained and lessons learned from a large portfolio of pathfinding 
projects and build on current investments, thus leveraging existing project outcomes. This 
requires an inclusive and integrative approach with programmes that bring together the many 
different actors into the HRIC, as its construction needs interdisciplinary collaboration with 
expertise from many disciplines e.g. economics, ICT, biomedical and health, social sciences 
and policy. In particular, frameworks for public-private partnerships such as IMI have shown 
a way to include industry in open transparent projects that also includes patients and other 
public bodies, SMEs and European researchers. Many of the mechanisms proposed in the 
Lamy report (prioritise research and innovation in EU and national budgets, build a true EU 
innovation policy that creates future markets, rationalise the EU funding landscape and 
achieve synergy with structural funds…)[52] and in the development of the Horizon Europe 
“Missions” [53] would also be well suited to the development of the HRIC and help bring 
together initiatives from the many funders, national and regional stakeholders. Other 
opportunities such as those proposed to be included in the Horizon Europe strategic workplan 
(e.g. the European Information Cloud, the European Institute of Technology and the European 
Council for Health Research [54, 55]) should be of interest to deploy innovations together with 
industry at the European level [56]. 
Furthermore, future programmes need to create incentives such that developed solutions are 
transformed into long term reusable resources and make sure that this infrastructure is 
deployed across the EU with development informed by ongoing research projects. The 
European Joint Programme on Rare Diseases (EJP-RD) [56] provides a good example of how 
infrastructure development can be linked with research projects at national and international 
levels. As in the EJP-RD, the European Strategy Forum on Research Infrastructures (ESFRI) can 
play a role in the development of HRIC. Two further aspects of EJP-RD are worth noting: the 
programme has a strong emphasis on the importance on the diverse workforce required with 
a training programme that stretches beyond academia and research networks to reach a 
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broad set of individuals in health systems and the education sector. Secondly, the research 
portfolio should fund broadly and recognise that successfully addressing many of the 
identified challenges will require a diverse portfolio of projects that avoid any artificial 
boundary between biomedical and health research. Horizon Europe should allow for linkages 
between the HRIC, ESFRI and other themes of Horizon Europe and, importantly, between HRIC 
and other funding sources such as the European Structural and Innovation Funds (ESIF) and 
the cutting-edge basic research successfully supported by the European Research Council 
(ERC) during the past decade [57, 58].  
The HRIC should enable investments in product development for future health-care solutions 
as well as allow health care providers to procure such solutions. People need to be an integral 
part of the innovation vision where the HRIC supports a highly skilled future workforce that 
makes Europe attractive for locating R&D investments. The experience gained in IMI public-
private partnership infrastructure projects such as eTRIKS and the European Medical 
Information Framework (EMIF) should be leveraged. Finally, the current and future EU 
Framework Programmes for Research and Innovation (Horizon 2020 and Horizon Europe) 
should consider mobilising funds to support novel pilot actions, pooling of data and resources 
across the EU, and demonstrate the benefits in advancing data sharing, integration and 
analysis across Europe, for the benefit of all citizens. 
 
Conclusions, recommendations and action points 
 
Clouds are increasingly becoming a key venue for enabling and hosting European and 
international collaborations, benefitting from the ability to hold data securely in a single 
location (or in few locations) and enable collaborative research on computational 
infrastructure used for analysis. In conclusion, a cloud-based federated data storage solution 
with interoperable data access services (see Table 1) to local repositories and modular 
environments that can be configured for a given use case seems to match the data needs of 
the EU research and medical institutions and of all other stakeholders. The choice of cloud 
technology provides the ability to manage rapidly growing datasets and provides users with 
access to the massive computational infrastructure needed for analysis. The federated, cloud 
based research environment - HRIC- described in this paper, would represent an added value 
to the entire biomedical and bioinformatics community, because single research institutes and 
medical institutions lack sufficient infrastructure capacity. The establishment of a 
transnational HRIC will allow the European research community at large to contribute to the 
global international leadership required to address societal and scientific challenges through 
transnational collaborations. In order to ensure the effective and efficient implementation of 
the European HRIC, the workshop participants endorsed the five recommendations and 
actions points presented in Table 2 to the EU and all stakeholders. 
 
 
Application A set of programs running on one or more computers allowing a 
user to perform a set of tasks 
Cloud Application An application running in the cloud 
Cloud Computing The delivery of IT services over a network (e.g. the Internet) by 
means of a combination of infrastructure, software and data 
hosted by one or more cloud providers using a service model 
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similar to that used by traditional utility companies (e. g. water or 
electricity) 
Cloud Federation The combination of infrastructure, software and services from 
separate networks and providers, having shared access 
mechanisms, to perform common actions, achieve load-balancing 
or optimize availability or costs 
Cloud Instance A virtual server or container of resources running on a physical 
host computer possibly hosting several independent instances 
(see virtualization) 
Cloud Marketplace An online marketplace of cloud services and applications 
operated by a Cloud Service Provider (CSP) 
Cloud Service Provider 
(CSP) 
A company or public entity that offers cloud services to individual 
users or other entities 
Cloud Storage A model of data storage in which data is hosted across one or 
more facilities by a hosting entity or CSP and remotely accessed 
by users over the Internet 
Container A type of virtualized instance running on a physical host server in 
isolated user spaces and possibly preloaded with applications 
Hybrid Cloud A cloud computing infrastructure comprised of a mix of public 
and private cloud and on-premise instances and resources 
Infrastructure The combination of hardware resources (network, computing, 
storage, etc.) and virtualized instances supporting an IT 
environment 
Infrastructure as a 
Service (IaaS) 
A model of cloud computing in which a CSP provides an 
infrastructure of virtualized resources to users as a service over a 
network (e.g. the Internet) 
On-Premise It refers to infrastructure or software run on computing resources 
physically hosted by the entity using them 
Platform A computer system where applications can run on or can be built 
with 
Platform as a Service 
(PaaS) 
A model of cloud computing in which a CSP provides the 
infrastructure and the platforms where users can run and manage 
their own applications as a service over a network (e.g. the 
Internet) 
Private Cloud A cloud infrastructure used by a single organization either on-
premise or hosted by a third-party CSP over the Internet or 
dedicated private networks 
Public Cloud A cloud infrastructure hosted by a CSP (or a Federation) and used 
by the public or multiple organizations across the Internet 
Software as a Service 
(SaaS) 
A model of cloud computing in which a CSP hosts and provides 
applications (software) to users as a service over a network (e.g. 
the Internet) 
Virtualization A technology that allows to run a software simulation of a 
physical computer where a full operating system and applications 
can be installed 
Table 1 : Glossary of cloud computing terms.  
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Recommendation Rationale Action points 
Provide and foster standards, good 
practices and guidelines necessary to 
establish the HRIC. 
The HRIC should be supported by predefined 
standards, data formats, protocols and templates. The 
data standards and guidelines applied in the HRIC 
should be designed as to facilitate interoperability 
between the diverse health systems and policies in 
Europe and globally. 
Suggest the adoption of data formats and 
architectures in policies, grant applications 
and projects calls, throughout the EU and its 
member states. 
Develop and certify the 
infrastructure and services required 
for operation of the HRIC. 
The HRIC should provide computational 
infrastructures and services, analytical and 
visualisation tools to all users as a platform to share 
knowledge, data and guidelines. Services for data 
sharing, security and analysis should be compliant 
with an EU certification system. 
- In future grant and project calls related to 
the development of the HRIC, the EU and 
the applicants should commit to comply 
with the highest standards of security, 
interoperability and reproducibility. 
- The EU should develop a certification 
system to validate compliance with the 
standards mentioned. 
Enable the HRIC to operate within an 
ethical and legal framework 
adequate for health systems. 
A robust ethical and legal framework has to be 
developed that defines rules for privacy, security, 
ownership, access and usage of data within the HRIC. 
A federated system architecture should be preferred 
as it allows for comparison of data and results, while 
complying with EU (GDPR) and international data 
protection and sharing rules. 
- In grants and project calls, federated and 
GDPR-compliant data architectures 
should be preferred. 
Establish a proper environment for 
the training of a new generation of 
data and medical scientists. 
Education and training of health professionals need to 
be updated with the HRIC in mind, considering both 
international standards and practices for data sharing 
as well as national environments and regulations. The 
EU should take inspiration in existing large and 
successful infrastructures that foster multidisciplinary 
teams, such as CERN. 
- Scientists and health professional in 
training should be made aware of the 
possibilities of the HRIC. 
- Communication in relevant professional 
channels should be strengthened.  
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Table 2: Summary of the recommendations, details on the rationale and suggestions for actions points directed to the funding agencies and the actors of the field.  
Fund public and private initiatives for 
the development of the HRIC through 
EU Framework Programmes 
(Horizon 2010 and Horizon Europe). 
The EU and its member states should together with 
private investors develop a coherent, ambitious and 
long-term action plan supported by innovative funding 
mechanisms that consolidate the outcomes from the 
existing project portfolio into a long-term operational 
infrastructure.  
- The EU should invest through calls and 
grants in order to build and consolidate 
the HRIC. 
- The existing industrial ecosystem should 
be supported, to remain competitive 
against the other actors in the world.  
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Figure 1 : Proposed general architecture of the HRIC European (inter)national databases, with varying data formats and data 
types are referenced in a metadata repository, following formatting rules of the Federated data commons as agreed at the 
HRIC governance level. The different users, after access control to the cloud, use the HRIC interface to access the repository, 
which gathers the relevant data and performs analysis, with outputs such as mathematical models, data visualisations, 
statistics and patient’s profiles, according to the users’ needs. 
 
 
 
Table 3: Relevant initiatives for the European Health Research and Innovation cloud 
PROJECT AIMS/SUMMARY Cloud model used References 
CORBEL project  Creating a platform for 
harmonised user access to 
biological and medical 
technologies, biological samples 
and data. The project has 
developed the data 
harmonisation, ethics guidance 
and user access protocols 
necessary for transnational access 
to both pre-clinical and clinical 
research infrastructures and is 
piloting access to participant level 
data from clinical trials43. 
Scalable cloud-based provision of 
data access and compute across 
infrastructures. 
 
 [59] 
ELIXIR EUROPEAN RESEARCH 
INFRASTRUCTURE with 21 
members and over 180 research 
organisations. ELIXIR is creating a 
Hybrid cloud ecosystem :  
i/ Local, private clouds (e.g. 
EMBL-EBI Embassy); 
 [60] 
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network of local instances of the 
European Genome-Phenome 
Archive that give users controlled 
and secure access to raw data and 
precomputed results44,45. 
ii/ National community clouds 
(e.g. cPouta, MetaCentrum cloud, 
de.NBI); 
iii/ European research and 
innovation oriented clouds (e.g. 
EOSC) 
iv/ Public/commercial compliant 
clouds (e.g. Google, Azure, AWS). 
 
European 
Translational 
Information 
and Knowledge 
Management 
Services 
(eTRIKS) 
IMI-funded highly scalable cloud-
based platform for translational 
research, information and 
knowledge management providing 
open-source applications that can 
securely host heterogeneous data 
types, including multi-omics data, 
preclinical laboratory data and 
clinical information, including 
longitudinal data sets. The 
platform is a robust translational 
research knowledge management 
system that is able to host other 
data mining applications and 
support the development of new 
analytical tools46.  
Scalable cloud-based platform for 
translational research and 
applications development. The 
Openstack technology is used to 
run a private cloud for eTRIKS. 
[61] 
European 
Medical 
Information 
Framework 
(EMIF) 
IMI-funded project that has 
successfully improved access to 
human health data via providing 
tools and workflows to discover, 
assess, access and (re)use human 
health data. The efforts of this IMI 
project are being extended 
through the EHDEN one. 
Research analytical service 
approaches via HER and cohort 
data platforms. 
 
[62, 63] 
Human Brain 
Project (HBP) 
Medical 
Informatics 
Platform 
The HBP Medical Informatics 
Platform allows researchers 
around the world to exploit 
medical data to create machine-
learning tools that can analyse 
these data for new insights into 
brain-related diseases. The 
Medical Informatics web-portal47 
provides a software framework 
based on federated and 
distributed computing that allows 
researchers to mine clinical data 
stored on hospital and laboratory 
servers, without moving the data 
from the servers where they reside 
and without compromising patient 
privacy. 
 
The HBP Joint Platform plans to 
adopt in cloud technology and 
provide those services through its 
computer centers JSC-Jülich and 
CSCS-Lugano together with BSC-
Barcelona, CINECA-Bologna and 
CEA-Saclay. 
 
Software infrastructure :  
i/ The (base) infrastructure layer 
is accessible through an 
“Infrastructure as a Service” 
(IaaS) interface; 
ii/ Tools to enable simulation and 
modeling as well as data analytics 
workflows for neuroscience that 
the HBP operates as a “Platform 
as a Service” (PaaS); 
[64] 
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iii/ Several software services for 
data-driven brain simulations and 
for virtual neurorobot design and 
operation offered in form of 
“Software as a Service” (SaaS). 
HBP operates the following SaaS: 
a/ Model driven brain 
simulations; 
b/ Neurorobotics simulation and 
development tools across the 
whole workflow the of 
neurorobotics life cycle. 
Human Brain 
Project (HBP) 
Knowledge 
Graph Data 
Platform 
The HPB Knowledge Graph (KG) is 
an online graph database 
accepting submissions of 
anonymized human data, animal 
data, and models from the brain. 
All data made discoverable and 
accessible through KG search have 
been curated. Data are also made 
available with integrated 
multilevel HBP Atlases, holding 
information about the brain in 
standard reference spaces.  
 
 [65] 
Helix Nebula The project is a pan-European 
public private partnership initiative 
led by EIROforum and leading 
commercial cloud computing 
partners. Since 2011, it has been 
piloting the use of cloud 
computing to enable complex data 
analyses and large-scale data 
sharing, with life science-oriented 
projects ranging from complex 
genome assembly to assessing 
somatic variation in the context of 
different types of cancer. 
Helix Nebula Science 
Cloud (HNSciCloud): 
Hybrid cloud platform linking 
together commercial cloud 
service providers and publicly 
funded research organisations’ 
in-house IT resources via 
the GEANT network to provide 
innovative solutions supporting 
data intensive science. 
These services support the 
connection of the research 
infrastructures identified in 
the ESFRI Roadmap to the 
nascent European Open Science 
Cloud (EOSC) intended to create a 
single digital research space for 
Europe’s 1.8 million researchers. 
 
[66]  
European Open 
Science Cloud 
(EOSC) 
The pilot project has recently 
investigated the benefits of data 
and cloud computer sharing at a 
pan-European level with life 
science-oriented projects on pan-
cancer analyses31 and imaging. 
This has been pursued across 
Cloud based services for open 
sciences - integration and 
consolidation of e-infrastructure 
platforms,  federation of existing 
European research 
infrastructures and scientific 
clouds. 
[25] 
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academic cloud computing 
environments located in Western 
and Eastern Europe as well as 
Canada. Similar initiatives have 
been launched in the USA8. 
PCAWG PCAWG - PANCANCER ANALYSIS 
OF WHOLE GENOMES  
The study is an international 
collaboration to identify common 
patterns of mutation in more than 
2,800 cancer whole genomes from 
the International Cancer Genome 
Consortium. This project is 
exploring the nature and 
consequences of somatic and 
germline variations in both coding 
and non-coding regions, with 
specific emphasis on cis-regulatory 
sites, non-coding RNAs, and large-
scale structural alterations. 
Hybrid cloud model 
The data coordinating center lists 
collaborative agreements with 
cloud providers AWS and an 
academic compute cloud 
resource maintained at the 
cancer collaboratory,  by the 
Ontario Institute for Cancer 
Research and hosted at the 
Compute Canada facility. 
 
[67, 68] 
RD-Connect RD-Connect is an integrated 
platform connecting databases, 
patient registry data, biobanks and 
clinical bioinformatics for rare 
disease research. 
The RD-Connect allow the 
integration of different data types 
(e.g. omics, clinical information, 
patient registries and biobanks). 
Those integrated data can be 
accessed and analysed by the 
scientific community to speed-up 
research, diagnosis and therapy 
development for patients with rare 
diseases to contribute for better 
health. 
 
Online secured platform 
connecting different types of 
patients related rare disease data 
enabling genome-phenome 
analysis. 
[69] 
COMPARE COMPARE, a network of 
collaborators of the Global 
Microbial Identifier initiative (GMI), 
aims to improve identification and 
mitigation of emerging infectious 
diseases and foodborne outbreaks. 
One serve all analytical 
framework and data exchange 
platform with various data 
integration for real time analysis 
and interpretation of sequence-
based pathogen. 
[70] [71] 
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Abstract  
 
The European Union (EU) initiative on the Digital Transformation of Health and Care (Digicare) 
aims at providing conditions for building a secure, flexible and decentralised digital health 
infrastructure. Creating a European Health Research and Innovation Cloud (HRIC) within this 
environment should enable data sharing and analysis for health research across the EU in 
compliance with data protection legislation while preserving the full trust of the participants. 
Such a HRIC should learn from and build on existing data infrastructures, integrate best 
practices, and focus on the concrete needs of the community in terms of technologies, 
governance, management, regulation and ethics requirements. Here we describe the vision 
and expected benefits of digital data sharing in health research activities and a roadmap 
fostering the opportunities while answering the challenges of implementing a HRIC. For this, 
we put forward five specific recommendations and action points to ensure that a European 
HRIC: 1) is built on established standards and guidelines, providing cloud technologies through 
an open and decentralised infrastructure; 2) is developed and certified to the highest 
standards of interoperability and data security that can be trusted by all stakeholders; 3) is 
supported by a robust ethical and legal framework compliant with the EU General Data 
Protection Regulation (GDPR); 4) establishes a proper environment for the training of new 
generations of data and medical scientists; 5) stimulates research and innovation in 
transnational collaborations through public and private initiatives and partnerships funded by 
the EU through Horizon 2020 and Horizon Europe. 
 3 
 
Background 
 
Genomics has brought life sciences into the realm of data sciences - large scale DNA and RNA 
sequencing is now routine in life-science and biomedical research with an estimate of up to 
60 million human genomes being available in the coming years [1, 2]. Recent innovations in 
medical research and healthcare, such as high-throughput genome sequencing, 
transcriptomics, proteomics, metabolomics, single-cell omics techniques, high-resolution 
imaging, electronic medical records (EMRs), big-data analytics and a plethora of internet-
connected health devices fundamentally change the infrastructure requirements for health 
research. 
Translating these new data together with clinical information into scientific insights and 
actionable outcomes for improving clinical care is a major challenge. As life-science and health 
research datasets rapidly grow larger, with an ever-increasing number of study participants 
required to detect meaningful but weak  signals among that may be blurred by a myriad of 
confounding biological, experimental or environmental factors, the computational resources 
required to process and analyse this big data increasingly outgrows the capabilities of even 
large research institutes. The various cCloud technologies and services listed in Table 1 are, 
based on shared commercial and private computer and storage resources  that can be 
provided on demand to users from a large number of different institutions conducting or 
participating in joint projects (Table 1). They, have emerged as powerful solutions to the 
challenges of collaborating in research on genomic, biomedical and health data. Biomedical 
and health research has yet to fully enter the bBig dData and cCloud computing era. The HRIC, 
as described in this manuscript, would help facilitate this transition, providing access to larger 
datasets, cutting-edge tools and knowledge, as envisioned in [3]. For example, the HRIC should 
ease the incorporation of domain expert knowledge into systems disease maps in a format 
that can be both understood by all stakeholders (patients and clinicians, scientists and drug 
developers), and processed by a high-performance computers, thus supporting the 
development of innovative medicines and diagnostics [4, 5]. Cloud technologies (through e.g. 
Hadoop applications) makes it possible to collaborate, access and reuse data also in situations 
when privacy concerns or regulation prohibits remote users from downloading data – an 
important benefit in Europe where national regulations can differ significantly. Clouds allow 
bringing algorithms to the data and as such can enable data sharing and joint processing 
without generating unnecessary copies of the data, which comes with potential benefits for 
data protectionCloud technologies (through e.g. Hadoop applications) makes it possible to 
collaborate, access and reuse data also in situations when privacy concerns or regulation 
prohibits remote users from downloading data – an important benefit in Europe where 
national regulations can differ significantly. Clouds allow bringing algorithms to the data and 
as such can enable data sharing and joint processing without generating unnecessary copies 
of the data, which comes with potential benefits for data protection [6, 7].. Clouds, 
additionally, enable performing computational analyses at a scale that individual institutions 
would struggle to manage Clouds, additionally, enable performing computational analyses at 
a scale where individual institutions would struggle [7].. Consequently, in the last few years 
the large international cancer and other genomics consortia have created specialized 
genomics and biomedical cloud environments, each supporting individual projects [2]. These 
projects have made important advances in connecting health research data across disciplines, 
organisations and national boundaries. For instance, in research on rare diseases, 
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 4 
international collaborations that integrate genomic, phenotypic, and clinical data have 
introduced new paradigms in diagnosis and care [8]. However, a project-based, fragmented 
landscape will not enable access and construction of large data cohorts that are required to 
address novel or broader biomedical questions that were not anticipated in individual projects 
when collecting inform consent from the participants, nor will it provide adequate data 
governance and containable cost models.  
Scaling and sustainably managing such solutions to support all European life scientists thus 
requires a coordinated action from science policy makers, funders and other actors in this 
complex ecosystem. Connecting Europe’s health data to advance the understanding of life and 
disease requires that research data and analysis tools, standards and computational services 
are made FAIR – i.e. findable, accessible, interoperable, and reusable for researchers across 
scientific disciplines and national boundaries [9]. Truly enabling personalised and digital 
medicine across Europe and beyond will require a connected digital infrastructure for 
Europe’s health data that supports systematic openness and integration of research data with 
real-world datasets (e.g. environmental monitoring data). generated inside all healthcare 
systems, government agencies, foundations and private organisations that will adopt it.(e.g. 
environmental monitoring data). 
On the 13th of March 2018, the Health directorate of the Directorate-General for Research and 
Innovation of the European Commission of the EU organised a workshop to explore the 
possibility and challenges involved in establishing a cloud for health research and innovation, 
accessible by researchers and health professionals throughout Europe, in line with 
recommendations for a European Innovation Council and the Horizon Europe 2021-2027 
framework programme [10, 11]. The cloud computing environment proposed in this 
manuscript builds upon the European Open Science Cloud (EOSC) initiative developed in the 
last few years by the European Commission [12], with a focus in the life science and medicine 
field. The EOSC aims at developing a trusted, open environment for the scientific community 
for storing, sharing and re-using scientific data and results. Overall, the authors feel that the 
cloud described in this manuscript, providing the biomedical and health research community 
with the technical infrastructure and services listed in Table 1 to support the development of 
innovative diagnostics methods and medical treatments, should become an integral part of 
the EOSC. The workshop gathered a broad range of experts from multiple biomedical research 
disciplines, health care, informatics, ethics and legislation, including representatives of more 
than 45 FP7 and Horizon 2020 (H2020) EU-funded collaborative projects. The participants 
explored requirements and developed a set of recommendations for a European “Health 
Research and Innovation Cloud” (HRIC) to connect researchers and health data sources in 
Europe [13] such that clinical data, software, computational resources, methods, clinical 
protocols, and publications, can be moreare widely and securely accessed and reused 
following the FAIR principles [9] than is currently possible with existing European research 
infrastrucures such as ELIXIR that form a network of heterogenous national nodes.  For 
example, tThe HRIC infrastructure would benefit from the aforementioned advantages of 
cloud computing for the archiving and dissemination of health data via compute clouds.  This 
paper summarises the main conclusions from the workshop and highlights five 
recommendations and action points to the EU and national stakeholders (Table 2). The 
recommendations are key issues that need to be addressed in order to link biological, clinical, 
environmental and lifestyle information (from single individuals to large cohorts) to the health 
and wellbeing status of patients and citizens over time, while making this wealth of data and 
information available for European health research and innovation in clinical care. 
Field Code Changed
Field Code Changed
Field Code Changed
Field Code Changed
Field Code Changed
Commented [BDM3]: RA4: ‘Which basic services will 
be provided by the HRIC? What types of applications 
will be used for tackling data integration?’ 
‘What types of innovation can one anticipate by 
development of HRIC?’ 
 
Please briefly answer those points.  
Commented [BDM4R3]: Niklas, Alberto 
Field Code Changed
Field Code Changed
 5 
  
The HRIC should be built on established standards and guidelines, to foster European-wide 
medical research 
 
Rationale 
Sharing of data, information and knowledge represents the most important functionality in 
the context of a HRIC. High-level standardisation, common exchange mechanisms, interfaces 
and protocols, and semantic interoperability form the foundation for widespread adoption of 
the  FAIR principles [9] in health research.  Data shared collaboratively in such health-related 
cloud projects are now largely standardised for the processing of genomic DNA read and 
genomic variant calling files. By comparison, the sharing of highly sensitive clinical and health 
data has thus far been much less developed hence representing a key future focus area, and 
numerous challenges remain with regard to sharing these data in a meaningful way. 
 
Existing standards and guidelines 
Many individual projects, in Europe and globally, have demonstrated the opportunities and 
the added value presented by connecting and exchanging data across countries via 
standardised protocols. Table 3 lists recent European projects that have developed towards 
clinical and health data exchange via cloud-based solutions. All those projects have developed 
and implemented worthy ideas that should be included in the HRIC. However, we envision the 
HRIC as a disease-agnostic environment, and on a larger scale than the platforms mentioned 
in Table 3. Moreover, the HRIC should not be tied to a single project or consortium, but should 
rather be under the governance of an independent body. International exchange of health 
research data holds tremendous potential in disease research by facilitating better 
investigation of disease causality and linking of genotypes and phenotypes, such as 
demonstrated in the Pan-Cancer Analysis of Whole Genomes (PCAWG) project, for example. 
An important aspect of the cloud-based data governance is that it allows sharing of data 
outside a consortium through a data request mechanism and a governance infrastructure that 
track participant consent, and data access. The cloud-based audit trail capabilities of the 
cloud-based research analyses that can be implemented at both data and infrastructure levels 
is a direct benefit to the data controllers. A standardised data model (or data access model) 
and/or standardised metadata models facilitate consolidation of different data sets and 
significantly increase the findability, the semantic interoperability and, by consequence, the 
reusability of data, and thus its ‘FAIRness’ [9, 14]. 
Workshop participants agreed that a first minimalistic and yet effective approach to data 
exchange should consist of a small number of initial online repositories containing references 
(e.g. links to render data sets findable) along with metadata (e.g. type and scale of content, 
specifications describing in what systems the data set may be stored and processed), and 
indications on how to gain access (e.g. requirements and point of contact). This could be 
designed as a metadata repository containing the metadata of data objects and information 
on how to gain access to them. The data objects as such may, or indeed should, be stored 
elsewhere.  
Beyond their metadata, however, data sets are bound to greatly differ, as research projects 
vary largely in scope. Not only would it be cumbersome to record a large number of 
parameters irrelevant to the specific question addressed, but it would also be problematic 
from an ethical viewpoint, considering patient personal data protection aspects [15]. It 
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 6 
therefore seems more promising to drive standardisation within research communities while 
looking out for opportunities for overall standardisation. 
Thus, the workshop envisioned the HRIC as a distributed collection of data repositories, people 
and services, which together make up a framework to share and operate as a federated data 
commons with reproducible software [2, 16-19], standards and expertise based on joint 
policies and guidelines to conduct health research as performed successfully in previous 
initiatives [2, 16-19]. . The need for federation is also highlighted in the proposed EU action 
plan for ‘Making sense of big data in health research’ [3]. Creating such a HRIC opens new 
frontiers for research and healthcare via the opportunities for strong international 
collaborations. 
Beyond Europe the HRIC should collaborate internationally to drive the development and 
widespread adoption of global standards and connectivity. OngoExisting initiatives exist in the 
USA, Canada, Africa and the United Kingdomoutside Europe [20, 21] andthat are aiming at 
developing global standards for the secure data exchange and securityof e.g. health and 
medical records within health information federations while tracking completeness of the 
supporting data [20, 21], as well as developing guidelines for data analytics and standardised 
workflows. T, thaeyt should be considered for the basis of the HRIC as this will. This provides 
the scientific community with means of reproducibility, version control and documentation, 
which will be an important vehicle to drive increased standardisation and connectivity. 
 
 
A European HRIC should be developed and certified to the highest standards of 
interoperability and data security 
 
Rationale 
The workshop participants enthusiastically endorsed the vision of the HRIC as a federated 
environment. Through work on the standardisation, harmonisation and integration of 
genomic data with other health-relevant information to optimise hypothesis-driven analyses, 
the major blockers for cross-border collaborations in translational research on disease 
prevention, treatment and management will be addressed through a federated HRIC 
infrastructure in which data sources remain at their location of origin and are made accessible 
to users through a metadata repository. Moreover, data security has to be integral to the 
development of the HRIC, using modern cryptology and access control techniques to ensure 
the protection of the patients’ data contained therein. 
 
Standards in interoperability and data security 
European health systems have different ways of managing and storing health data, making 
the exchange of clinical data between the EU member states complex. The challenges are well 
illustrated by the use of eHealth records and their use as secondary research material. In a 
recent OECD report [22] ten countries reported comprehensive record sharing within one 
country-wide system designed to support each patient having only one EHR (Supplementary 
Table.). These countries are Estonia, Finland, France, Greece, Ireland, Latvia, Luxembourg, 
Poland, Slovakia and the United Kingdom (England, Northern Ireland, Scotland and Wales). In 
these countries, plans call for patient records to be shared among physician offices and 
between physicians and hospitals regarding patient treatment, current medications, and 
laboratory tests and medical images. Some have already implemented part or all these 
functionalities, while others are progressing toward it. In other countries key aspects of record 
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sharing are managed at sub-national level only, such as within provinces, states, regions or 
networks of health care organisations (for example, Austria, Germany, Italy, Netherlands, 
Sweden, and Spain; Supplementary Table). Among them, all have implemented or are 
planning the implementation of a national information exchange that enables key elements 
to be shared country-wide. Based on the recent reports of the European Commission [23], 
Belgium, Malta, Portugal, Romania and Slovenia are now developing national EHR systems, 
leading to a total of 16 EU member states providing such services. 
Within the framework of the Joint Action on Rare Cancers, an EU initiative that brings together 
European research centres, policy makers and other stakeholders with the aim to set the 
agenda at national level, an analysis was made on the status of eHealth medical records in the 
EU member states. This work builds on the OECD study and complements this with 
information provided by the European Commission on the national laws on EHRs in the EU 
member states [24]. Thus all EU countries are investing in the development of clinical EHRs, 
but only some countries are moving forward the possibility of data extraction for research, 
the provision of statistics and the enablement of other uses that serve the public interest (P. 
Bogaert, personal communication). Countries that develop EHR systems that combine or 
virtually link data together to capture patient health care histories have the potential to be 
used also for long-term follow-up of cancer patients. Figure 1 shows how data from various 
sources can be integrated to provide a full picture of patients’ health status over time and 
carry out research for patterns and anomalies in large populations using the specific 
combinations of data and analysis resources relevant for each research project, while ensuring 
compliance with security and data protection regulations. 
The H2020-funded project European Open Science Cloud (EOSC)-Life [25] is developing 
policies, specifications and tools for the management of data for biological and medical 
research including  aspects of eHealth data. The use of common metadata standards, 
developed in EOSC-Life, as a foundation for remote data discovery and access was emphasised 
by the workshop participants as a key enabler for the HRIC. For instance, practical and legal 
considerations for cloud computing of patient data, which include the responsible use of 
federated and hybrid clouds set up between academic and industrial partners have been put 
forward by early EOSC pilot projects [26]. 
The workshop participants emphasised that sustainability aspects are critical and must be 
considered from the start. To ensure that a HRIC could respond properly to emerging needs, 
innovation and technology changes, a distributed federated storage solution offering access 
to FAIR data and services should be built according to modularity principles. In particular, due 
to the long-term nature of a HRIC, due consideration should be given to deploying generic and 
modular computational methods and/or data storage management systems, while the 
information and communications technology (ICT) infrastructure should be flexible, portable 
and expandable.  
The million European genomes initiative [27] is a case in point: eighteen member states have 
already signed the Genomics Declaration of Cooperation [28] to enable cross-border access 
to genomic databases and other health information. This federation of national initiatives [28] 
will provide secure access to such data resources in the member states to enable the discovery 
of personalised therapies and diagnostics for the benefit of patients. The initiative involves 
aligning strategies of ongoing national genomic sequencing campaigns with complementary 
de novo genome sequencing to obtain a total cohort of 1 million Europeans, accessible in a 
transnational framework, by 2022 [29]. The HRIC would form a basis for such large-scale, 
permanent collaborations. 
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The workshop participants recognise that ensuring a maximal data security is paramount to 
build and maintain trust with the European citizens. To address this issue, we suggest using 
modern cryptology such as blockchain to ensure data security by design, and holding regular 
data security assessment (e.g. through hackathons and/or commercial security audits). As 
shown in recent literature, the use of blockchain in biomedical research is still in its infancy 
[30]. However, blockchain or other advanced cryptology tools that can be used to protect data 
in a cloud environment could prove useful for the secure and trustworthy implementation of 
the HRIC [31]. 
 
The HRIC must be supported by a robust ethics and legal framework compliant with the 
GDPR 
 
Rationale 
Compliance with GDPR and other data protection laws, as well as enforcing an ethical usage 
of data is paramount to gain the general public’s support and trust in the HRIC.  
 
Existing ethics and legal framework 
Unblocking the legal and administrative barriers for sharing human research data across 
geographical and organisational boundaries will, if the trust of research participants is 
preserved, pave the way for continent-scale cohorts in life science research. This will represent 
a significant innovation as sharing and joint analysis of sensitive data has until now been 
severely limited because of the different restrictions inherent to the different classes of 
sensitive data. By using a federated database model, with a metadata repository within the 
HRIC cloud encrypted environment, data security is maintained while innovative data analyses 
can be performed by bringing the algorithms to the data rather than centralizing the data [32]. 
Federation, rather than full integration of all available resources, poses an important challenge 
for implementation and deployment of an effective HRIC. The set-up and functioning of a HRIC 
requires a robust foundation of legal agreements and ethics rules and procedures, as well as 
security and data protection compliance protocols. Importantly these elements must be 
introduced during the conception and design phase as part of its governance. This is essential 
in order to allow the different actorsHRIC actors providing access to their data sources, 
managing them within the cloud, and accessing these resources  to incorporate policy 
requirements into the design and manage the complexity involved in implementing simple 
and intuitive user interfaces and project portals. This may be challenging considering the 
heterogeneity of health systems and health market accesses across Europe and will need the 
sharing of a common agreed vision across EU member states.  
Ethical, societal and privacy considerations for (re)using health related data have been 
outlined in the Code of Practice on Secondary Use of Medical Research Data developed in the 
European Translational Information and Knowledge Management Services (eTRIKS) project 
funded by the Innovative Medicines Initiative (IMI) [33]. In addition to clear and explicit 
consent, explicit dissent may need to be considered for the use/re-use of data. Ultimately, 
each citizen and patient must be able to access her/his own data and know when and where 
it has been used and for what purpose. In addition, the difficult question of the business model 
of using those data should be discussed at various levels from ethical, societal and economical 
standpoints taking into account potential future developments of products and services using 
personal medical data. Furthermore, the goal of providing the citizens with personalised 
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services requires technical advancements in the collection and analysis of data (e.g. in data 
analytics and machine learning). For this type of usage, simple consent mechanisms might not 
be sufficient. For example, how should a clear data-collection purpose statement be defined, 
if data is collected for multiple usage scenarios across a distributed/federated cloud in which 
actors from different geographical and legislative environments will need to interact and 
cooperate? Would an excessive number of consent requests minimise data provision for 
research or clinical applications? Another level of complexity is introduced by the 
heterogeneity of data protection and privacy regulations when the data originate from states 
within federated national health systems (e.g. Germany, Italy). Development of large-scale 
European access mechanisms will require open consultation and engagement with national 
policymakers, patient organisations and the wider society to build the trust and confidence 
needed for widespread adoption and sustainable operations. 
In addition to technical, ethical and legal specifications, a global integrated governance model 
needs to be established for the HRIC in line with that of the EOSC, regulating roles and, 
responsibilities of all contributing institutions and users, and procedures for authentication 
and access control to individual resources. Principles, with specific guidelines on 
implementation into a HRIC environment, will need to be developed in order to manage and 
regulate aspects such as ownership, access, transparency, sharing, integration, 
standardisation of data and metadata formats, tools and frameworks, while ensuring 
confidentiality and sustainability. All these principles need to be developed with the 
overarching objective of providing benefit to and preserving the trust of patients and the 
general public. 
Health data mostly represents sensitive data, which need to be managed to preserve the trust 
of patients, research participants and the general public, respect social norms and naturally 
comply with the rules and regulations of data protection laws, notably the EU GDPR [15]. 
Although the GDPR directly applies across the EU and its provisions prevail over national laws, 
EU member states retain the ability to introduce in their own national legislation certain 
derogations provided for by the GDPR itself. The GDPR also introduces the notions of 'Privacy 
by Design', which means that any organisation that processes personal data, must ensure that 
privacy is built into a system during the whole life cycle of the system or process; and 'Privacy 
by Default', which means that the strictest privacy settings should apply by default, without 
any manual input from the end user. In addition, any personal data provided by the user to 
enable the optimal use of a given health dataset should only be kept for the amount of time 
necessary to provide the intended product or service [15].  
Thus, successfully linking and accessing biomedical and health data across Europe will require 
many different disciplines and specialists working together with a coordination effort that 
should encompass controlled access mechanisms to ensure compliance with privacy and data 
protection regulations. Data providers need logging and monitoring functionalities to comply 
with the GDPR and to enable tracking of data and methods within the system, controlling 
instances and routines that check for the adherence of predefined standards and formats to 
guarantee data integrity. Access mechanisms need to be developed that support the 
researchers, data producers and data analysts to request permissions and fulfil reporting 
requirements for data use in national and international research projects, which represents a 
significant regulatory, political and sustainability challenge [34]. These include in particular 
considerations about the rights of patient donors and research participants, taking into 
account the data protection aspects of various legal systems and local regulations. 
Researchers have to face differences in the understanding of the right to data protection in 
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those different regional or national European ecosystems. There is an urgent need for 
standardised, usable, data-protection-policy-compliant solutions for sensitive data sharing 
capable of integrating and analysing health data coming from different sources, organisations 
and potentially from different research disciplines. These aspects are subject to ongoing 
discussions and debates in the EOSC initiative [35] and for instance, progress has been made 
in the Human Brain Project through its Ethics and Society sub-project in collaboration with the 
project platforms [36, 37]. Other examples of data sharing compliant with data protection 
policies can be found in the recent literature [38-45]. Furthermore, there is the issue of 
capacity with the amount of data starting to strain the infrastructure of any individual hospital 
or research institute. Thus, the interplay between privacy, data security and access control on 
one hand and access (including cost-recovery models) to storage, computational and analysis 
resources on the other hand will be a defining element of the policy and technology 
development of a decentralised digital health infrastructure. The evolution of a cloud model 
that could be used in European health research will also have to take into account other 
specific aspects of the GDPR [15]. For instance, the European Commission intends to facilitate 
the free flow of non-personal data in the European Digital Single Market, and for health-
related research participants it codifies the ‘right to be forgotten’. It stipulates that patient 
donors should be able to retain control over their data regardless of technological 
developments. A European HRIC could be an important enabler for researchers to comply with 
these requirements. For example, once certain conditions are met between European and 
international partners, including those pertaining to data protection and use, federated and 
hybrid clouds could facilitate the deletion of data sets once a donor exercises her/his ‘right to 
be forgotten’, which thus could minimise the necessary transfer of large raw data sets across 
borders, as the deletion can be performed in the original dataset and easily propagated to the 
relevant federated data sources. 
 
A proper training environment for HRIC developers and users should be established 
 
Rationale 
The workshop identified the lack of trained personnel, with solid skills in both medical and 
data analytical fields as one of the major bottlenecks when dealing with ‘medical big data’ [3].  
 
Need for training and ideas 
Indeed, effectively developing, operating and maintaining the HRIC will pose serious 
challenges and require the training of a new generation of data scientists able to navigate 
smoothly and efficiently between computational, security and medical disciplines. This 
includes clinical researchers, bioinformaticians, data analysts, data managers, software 
engineers, cloud engineers, other IT-specialists, ethics officers, and data protection specialists, 
which represent an essential new field of expertise. Finding professionals that cover more 
than one or two of the above-described disciplines is nearly impossible. Furthermore, 
communication between this comprehensive mix of clinical researchers, data managers and 
IT/bioinformatics specialists needs to be improved, requiring a governance structure well 
beyond that of a standard research setting. The EU should take inspiration from existing large 
and successful infrastructures that foster multidisciplinary teams, such as CERN [46, 47]. Thus, 
it is necessary to rethink the training and education of health professionals and to update 
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them with the HRIC in mind, considering both international standards and practices for data 
sharing as well as national environments and regulations.  
 
Multiple funding mechanisms are required to drive the development of the HRIC and 
support its broad use in research projects 
 
Rationale 
Delivering the HRIC requires an ambitious reshaping of the European landscape for health 
data and research through appropriate funding schemes that enable transformation of 
fragmented ICT resources and project-centric solutions for data access and governance into a 
long-term, coherent service ecosystem that can be accessed by users transnationally.  
 
Need for innovative public-private funding initiatives 
Indeed, the HRIC needs a trusted and transparent innovation approach that recognises the 
importance of a clear, long-term ambition in the programme to support the participation of 
industry and small to medium enterprises (SME) in joint projects with a broad set of societal 
actions. In particular, there is a need to support the EU ICT industrial/SME innovation 
ecosystem in order to demonstrate the benefits in advancing data sharing, integration and 
analysis across Europe, for the benefit of all citizens, thus creating a foundation for attractive 
private investments. 
For this purpose, targeted EU funding mechanisms also involving private investors need to 
support the development of HRIC-compliant services for data sharing and analysis in health-
related research projects (i.e. through reimbursement for storage and computing costs) with 
incentives to reuse and extend existing infrastructures that favour national HRIC participation 
rather than rebuilding and fragmenting solutions. Moreover, the EU ICT industrial ecosystem 
must be supported in order to alleviate the risks associated with storing and sharing data 
across cloud systems operated by non-EU companies. The EU has established a strict privacy 
and ethics policy through the implementation of the GDPR legislation, binding for all operators 
active on the EU territory [48-51].  
European funders, science policy makers and other actors need to develop mechanisms that 
bring together experience gained and lessons learned from a large portfolio of pathfinding 
projects and build on current investments, thus leveraging existing project outcomes. This 
requires an inclusive and integrative approach with programmes that bring together the many 
different actors into the HRIC, as its construction needs interdisciplinary collaboration with 
expertise from many disciplines e.g. economics, ICT, biomedical and health, social sciences 
and policy. In particular, frameworks for public-private partnerships such as IMI have shown 
a way to include industry in open transparent projects that also includes patients and other 
public bodies, SMEs and European researchers. Many of the mechanisms proposed in the 
Lamy report (prioritise research and innovation in EU and national budgets, build a true EU 
innovation policy that creates future markets, rationalise the EU funding landscape and 
achieve synergy with structural funds…)[52] and in the development of the Horizon Europe 
“Missions” [53] would also be well suited to the development of the HRIC and help bring 
together initiatives from the many funders, national and regional stakeholders. Other 
opportunities such as those proposed to be included in the Horizon Europe strategic workplan 
(e.g. the European Information Cloud, the European Institute of Technology and the European 
Council for Health Research [54, 55]) should be of interest to deploy innovations together with 
industry at the European level [56]. 
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Furthermore, future programmes need to create incentives such that developed solutions are 
transformed into long term reusable resources and make sure that this infrastructure is 
deployed across the EU with development informed by ongoing research projects. The 
European Joint Programme on Rare Diseases (EJP-RD) [56] provides a good example of how 
infrastructure development can be linked with research projects at national and international 
levels. As in the EJP-RD, the European Strategy Forum on Research Infrastructures (ESFRI) can 
play a role in the development of HRIC. Two further aspects of EJP-RD are worth noting: the 
programme has a strong emphasis on the importance on the diverse workforce required with 
a training programme that stretches beyond academia and research networks to reach a 
broad set of individuals in health systems and the education sector. Secondly, the research 
portfolio should fund broadly and recognise that successfully addressing many of the 
identified challenges will require a diverse portfolio of projects that avoid any artificial 
boundary between biomedical and health research. Horizon Europe should allow for linkages 
between the HRIC, ESFRI and other themes of Horizon Europe and, importantly, between HRIC 
and other funding sources such as the European Structural and Innovation Funds (ESIF) and 
the cutting-edge basic research successfully supported by the European Research Council 
(ERC) during the past decade [57, 58].  
The HRIC should enable investments in product development for future health-care solutions 
as well as allow health care providers to procure such solutions. People need to be an integral 
part of the innovation vision where the HRIC supports a highly skilled future workforce that 
makes Europe attractive for locating R&D investments. The experience gained in IMI public-
private partnership infrastructure projects such as eTRIKS and the European Medical 
Information Framework (EMIF) should be leveraged. Finally, the current and future EU 
Framework Programmes for Research and Innovation (Horizon 2020 and Horizon Europe) 
should consider mobilising funds to support novel pilot actions, pooling of data and resources 
across the EU, and demonstrate the benefits in advancing data sharing, integration and 
analysis across Europe, for the benefit of all citizens. 
 
Conclusions, recommendations and action points 
 
Clouds are increasingly becoming a key venue for enabling and hosting European and 
international collaborations, benefitting from the ability to hold data securely in a single 
location (or in few locations) and enable collaborative research on computational 
infrastructure used for analysis. In conclusion, a cloud-based federated data storage solution 
with interoperable data access services (see Table 1) to local repositories and modular 
environments that can be configured for a given use case seems to match the data needs of 
the EU research and medical institutions and of all other stakeholders. The choice of cloud 
technology provides the ability to manage rapidly growing datasets and provides users with 
access to the massive computational infrastructure needed for analysis. The federated, cloud 
based research environment - HRIC- described in this paper, would represent an added value 
to the entire biomedical and bioinformatics community, because single research institutes and 
medical institutions lack sufficient infrastructure capacity. The establishment of a 
transnational HRIC will allow the European research community at large to contribute to the 
global international leadership required to address societal and scientific challenges through 
transnational collaborations. In order to ensure the effective and efficient implementation of 
the European HRIC, the workshop participants endorsed the five recommendations and 
actions points presented in Table 2 to the EU and all stakeholders. 
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Application A set of programs running on one or more computers allowing a 
user to perform a set of tasks 
Cloud Application An application running in the cloud 
Cloud Computing The delivery of IT services over a network (e.g. the Internet) by 
means of a combination of infrastructure, software and data 
hosted by one or more cloud providers using a service model 
similar to that used by traditional utility companies (e. g. water or 
electricity) 
Cloud Federation The combination of infrastructure, software and services from 
separate networks and providers, having shared access 
mechanisms, to perform common actions, achieve load-balancing 
or optimize availability or costs 
Cloud Instance A virtual server or container of resources running on a physical 
host computer possibly hosting several independent instances 
(see virtualization) 
Cloud Marketplace An online marketplace of cloud services and applications 
operated by a Cloud Service Provider (CSP) 
Cloud Service Provider 
(CSP) 
A company or public entity that offers cloud services to individual 
users or other entities 
Cloud Storage A model of data storage in which data is hosted across one or 
more facilities by a hosting entity or CSP and remotely accessed 
by users over the Internet 
Container A type of virtualized instance running on a physical host server in 
isolated user spaces and possibly preloaded with applications 
Hybrid Cloud A cloud computing infrastructure comprised of a mix of public 
and private cloud and on-premise instances and resources 
Infrastructure The combination of hardware resources (network, computing, 
storage, etc.) and virtualized instances supporting an IT 
environment 
Infrastructure as a 
Service (IaaS) 
A model of cloud computing in which a CSP provides an 
infrastructure of virtualized resources to users as a service over a 
network (e.g. the Internet) 
On-Premise It refers to infrastructure or software run on computing resources 
physically hosted by the entity using them 
Platform A computer system where applications can run on or can be built 
with 
Platform as a Service 
(PaaS) 
A model of cloud computing in which a CSP provides the 
infrastructure and the platforms where users can run and manage 
their own applications as a service over a network (e.g. the 
Internet) 
Private Cloud A cloud infrastructure used by a single organization either on-
premise or hosted by a third-party CSP over the Internet or 
dedicated private networks 
Public Cloud A cloud infrastructure hosted by a CSP (or a Federation) and used 
by the public or multiple organizations across the Internet 
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Software as a Service 
(SaaS) 
A model of cloud computing in which a CSP hosts and provides 
applications (software) to users as a service over a network (e.g. 
the Internet) 
Virtualization A technology that allows to run a software simulation of a 
physical computer where a full operating system and applications 
can be installed 
Table 1 : Glossary of cloud computing terms.  
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Recommendation Rationale Action points 
Provide and foster standards, good 
practices and guidelines necessary to 
establish the HRIC. 
The HRIC should be supported by predefined 
standards, data formats, protocols and templates. The 
data standards and guidelines applied in the HRIC 
should be designed as to facilitate interoperability 
between the diverse health systems and policies in 
Europe and globally. 
Suggest the adoption of data formats and 
architectures in policies, grant applications 
and projects calls, throughout the EU and its 
member states. 
Develop and certify the 
infrastructure and services required 
for operation of the HRIC. 
The HRIC should provide computational 
infrastructures and services, analytical and 
visualisation tools to all users as a platform to share 
knowledge, data and guidelines. Services for data 
sharing, security and analysis should be compliant 
with an EU certification system. 
- In future grant and project calls related to 
the development of the HRIC, the EU and 
the applicants should commit to comply 
with the highest standards of security, 
interoperability and reproducibility. 
- The EU should develop a certification 
system to validate compliance with the 
standards mentioned. 
Enable the HRIC to operate within an 
ethical and legal framework 
adequate for health systems. 
A robust ethical and legal framework has to be 
developed that defines rules for privacy, security, 
ownership, access and usage of data within the HRIC. 
A federated system architecture should be preferred 
as it allows for comparison of data and results, while 
complying with EU (GDPR) and international data 
protection and sharing rules. 
- In grants and project calls, federated and 
GDPR-compliant data architectures 
should be preferred. 
Establish a proper environment for 
the training of a new generation of 
data and medical scientists. 
Education and training of health professionals need to 
be updated with the HRIC in mind, considering both 
international standards and practices for data sharing 
as well as national environments and regulations. The 
EU should take inspiration in existing large and 
successful infrastructures that foster multidisciplinary 
teams, such as CERN. 
- Scientists and health professional in 
training should be made aware of the 
possibilities of the HRIC. 
- Communication in relevant professional 
channels should be strengthened.  
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Table 2: Summary of the recommendations, details on the rationale and suggestions for actions points directed to the funding agencies and the actors of the field.  
Fund public and private initiatives for 
the development of the HRIC through 
EU Framework Programmes 
(Horizon 2010 and Horizon Europe). 
The EU and its member states should together with 
private investors develop a coherent, ambitious and 
long-term action plan supported by innovative funding 
mechanisms that consolidate the outcomes from the 
existing project portfolio into a long-term operational 
infrastructure.  
- The EU should invest through calls and 
grants in order to build and consolidate 
the HRIC. 
- The existing industrial ecosystem should 
be supported, to remain competitive 
against the other actors in the world.  
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Figure 1 : Proposed general architecture of the HRIC European (inter)national databases, with varying data formats and data 
types are referenced in a metadata repository, following formatting rules of the Federated data commons as agreed at the 
HRIC governance level. as agreed at the HRIC governance level. The different users, after access control to the cloud, use the 
HRIC interface to access the repository, which gathers the relevant data and performs analysis, with outputs such as 
mathematical models, data visualisations, statistics and patient’s profiles, according to the users’ needs. 
 
 
 
Table 3: Relevant initiatives for the European Health Research and Innovation cloud 
PROJECT AIMS/SUMMARY Cloud model used References 
CORBEL project  Creating a platform for 
harmonised user access to 
biological and medical 
technologies, biological samples 
and data. The project has 
developed the data 
harmonisation, ethics guidance 
and user access protocols 
necessary for transnational access 
to both pre-clinical and clinical 
research infrastructures and is 
piloting access to participant level 
data from clinical trials43. 
Scalable cloud-based provision of 
data access and compute across 
infrastructures. 
 
 [59] 
ELIXIR EUROPEAN RESEARCH 
INFRASTRUCTURE with 21 
members and over 180 research 
organisations. ELIXIR is creating a 
Hybrid cloud ecosystem :  
i/ Local, private clouds (e.g. 
EMBL-EBI Embassy); 
 [60] 
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network of local instances of the 
European Genome-Phenome 
Archive that give users controlled 
and secure access to raw data and 
precomputed results44,45. 
ii/ National community clouds 
(e.g. cPouta, MetaCentrum cloud, 
de.NBI); 
iii/ European research and 
innovation oriented clouds (e.g. 
EOSC) 
iv/ Public/commercial compliant 
clouds (e.g. Google, Azure, AWS). 
 
European 
Translational 
Information 
and Knowledge 
Management 
Services 
(eTRIKS) 
IMI-funded highly scalable cloud-
based platform for translational 
research, information and 
knowledge management providing 
open-source applications that can 
securely host heterogeneous data 
types, including multi-omics data, 
preclinical laboratory data and 
clinical information, including 
longitudinal data sets. The 
platform is a robust translational 
research knowledge management 
system that is able to host other 
data mining applications and 
support the development of new 
analytical tools46.  
Scalable cloud-based platform for 
translational research and 
applications development. The 
Openstack technology is used to 
run a private cloud for eTRIKS. 
[61] 
European 
Medical 
Information 
Framework 
(EMIF) 
IMI-funded project that has 
successfully improved access to 
human health data via providing 
tools and workflows to discover, 
assess, access and (re)use human 
health data. The efforts of this IMI 
project are being extended 
through the EHDEN one. 
Research analytical service 
approaches via HER and cohort 
data platforms. 
 
[62, 63] 
Human Brain 
Project (HBP) 
Medical 
Informatics 
Platform 
The HBP Medical Informatics 
Platform allows researchers 
around the world to exploit 
medical data to create machine-
learning tools that can analyse 
these data for new insights into 
brain-related diseases. The 
Medical Informatics web-portal47 
provides a software framework 
based on federated and 
distributed computing that allows 
researchers to mine clinical data 
stored on hospital and laboratory 
servers, without moving the data 
from the servers where they reside 
and without compromising patient 
privacy. 
 
The HBP Joint Platform plans to 
adopt in cloud technology and 
provide those services through its 
computer centers JSC-Jülich and 
CSCS-Lugano together with BSC-
Barcelona, CINECA-Bologna and 
CEA-Saclay. 
 
Software infrastructure :  
i/ The (base) infrastructure layer 
is accessible through an 
“Infrastructure as a Service” 
(IaaS) interface; 
ii/ Tools to enable simulation and 
modeling as well as data analytics 
workflows for neuroscience that 
the HBP operates as a “Platform 
as a Service” (PaaS); 
[64] 
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iii/ Several software services for 
data-driven brain simulations and 
for virtual neurorobot design and 
operation offered in form of 
“Software as a Service” (SaaS). 
HBP operates the following SaaS: 
a/ Model driven brain 
simulations; 
b/ Neurorobotics simulation and 
development tools across the 
whole workflow the of 
neurorobotics life cycle. 
Human Brain 
Project (HBP) 
Knowledge 
Graph Data 
Platform 
The HPB Knowledge Graph (KG) is 
an online graph database 
accepting submissions of 
anonymized human data, animal 
data, and models from the brain. 
All data made discoverable and 
accessible through KG search have 
been curated. Data are also made 
available with integrated 
multilevel HBP Atlases, holding 
information about the brain in 
standard reference spaces.  
 
 [65] 
Helix Nebula The project is a pan-European 
public private partnership initiative 
led by EIROforum and leading 
commercial cloud computing 
partners. Since 2011, it has been 
piloting the use of cloud 
computing to enable complex data 
analyses and large-scale data 
sharing, with life science-oriented 
projects ranging from complex 
genome assembly to assessing 
somatic variation in the context of 
different types of cancer. 
Helix Nebula Science 
Cloud (HNSciCloud): 
Hybrid cloud platform linking 
together commercial cloud 
service providers and publicly 
funded research organisations’ 
in-house IT resources via 
the GEANT network to provide 
innovative solutions supporting 
data intensive science. 
These services support the 
connection of the research 
infrastructures identified in 
the ESFRI Roadmap to the 
nascent European Open Science 
Cloud (EOSC) intended to create a 
single digital research space for 
Europe’s 1.8 million researchers. 
 
[66]  
European Open 
Science Cloud 
(EOSC) 
The pilot project has recently 
investigated the benefits of data 
and cloud computer sharing at a 
pan-European level with life 
science-oriented projects on pan-
cancer analyses31 and imaging. 
This has been pursued across 
Cloud based services for open 
sciences - integration and 
consolidation of e-infrastructure 
platforms,  federation of existing 
European research 
infrastructures and scientific 
clouds. 
[25] 
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academic cloud computing 
environments located in Western 
and Eastern Europe as well as 
Canada. Similar initiatives have 
been launched in the USA8. 
PCAWG PCAWG - PANCANCER ANALYSIS 
OF WHOLE GENOMES  
The study is an international 
collaboration to identify common 
patterns of mutation in more than 
2,800 cancer whole genomes from 
the International Cancer Genome 
Consortium. This project is 
exploring the nature and 
consequences of somatic and 
germline variations in both coding 
and non-coding regions, with 
specific emphasis on cis-regulatory 
sites, non-coding RNAs, and large-
scale structural alterations. 
Hybrid cloud model 
The data coordinating center lists 
collaborative agreements with 
cloud providers AWS and an 
academic compute cloud 
resource maintained at the 
cancer collaboratory,  by the 
Ontario Institute for Cancer 
Research and hosted at the 
Compute Canada facility. 
 
[67, 68] 
RD-Connect RD-Connect is an integrated 
platform connecting databases, 
patient registry data, biobanks and 
clinical bioinformatics for rare 
disease research. 
The RD-Connect allow the 
integration of different data types 
(e.g. omics, clinical information, 
patient registries and biobanks). 
Those integrated data can be 
accessed and analysed by the 
scientific community to speed-up 
research, diagnosis and therapy 
development for patients with rare 
diseases to contribute for better 
health. 
 
Online secured platform 
connecting different types of 
patients related rare disease data 
enabling genome-phenome 
analysis. 
[69] 
COMPARE COMPARE, a network of 
collaborators of the Global 
Microbial Identifier initiative (GMI), 
aims to improve identification and 
mitigation of emerging infectious 
diseases and foodborne outbreaks. 
One serve all analytical 
framework and data exchange 
platform with various data 
integration for real time analysis 
and interpretation of sequence-
based pathogen. 
[70] [71] 
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